Loading...
  • granulocyte
  • A medication referred to as granulocyte colony-stimulating factor (Neupogen) is usually given daily for 4 or 5 days by injection, in order to increase the number of stem cells present in your blood. (verywellhealth.com)
  • At one time it was thought that granulocyte stimulating factor may increase the risk of leukemia in those who received it, but that does not appear to be the case, and in one large study the incidence of leukemia in people who had received granulocyte stimulating factor in preparation for donating stem cells was actually lower than the average in the population. (verywellhealth.com)
  • The most bothersome side effects of a stem cell donation usually occur in the days before the donation and are related to the side effects of the injections of granulocyte stimulating factor. (verywellhealth.com)
  • 1990) Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor. (springer.com)
  • Granulocyte colony-stimulating factor (G-CSF ) in combination with stem cell factor (SCF ) mobilizes more primitive HSC than each factor alone in nonhuman primates, dogs, and mice. (bloodjournal.org)
  • 95% donor CD3+ T cells and mixed chimerism is the detection of peripheral blood donor T cells (CD3+) and granulocytes (CD33+) as a proportion of the total peripheral blood T cell and granulocyte population, respectively. (clinicaltrials.gov)
  • Followed by Stem Cell Rescue
  • Consolidation therapy followed by stem cell rescue repeats every 28 days for 3 courses (C) and 3D-CRT to the brain (and the spine if needed) 5 days a week for 5-6 weeks (R), the order of which depends on patient age, in the absence of disease progression or unacceptable toxicity. (clinicaltrials.gov)
  • radiation
  • I. To determine the 6-, 12-, and 24-month event-free survival and overall survival of children (birth to 21 years of age) with atypical teratoid/rhabdoid CNS tumors (AT/RT), diagnosed based on histology, immunophenotyping, and modern molecular and immunohistochemical analysis of INI1, treated with surgery, intensive chemotherapy combined with stem cell rescue, and radiation therapy. (clinicaltrials.gov)
  • doses
  • Less is known about the minimal doses of CD34 + cells that would still support enhanced hematopoietic reconstitution after nonmyeloablative conventional therapy regimens. (hindawi.com)